7 Best Cancer Centers in Hyderabad for Blood Cancer Care

Blood cancer patients in Hyderabad have access to seven specialized cancer centers offering thorough hematology oncology, bone marrow transplant, and 24/7 support services.

Choosing the right center depends on matching your diagnosis—whether acute leukemia requiring intensive transplant or maintenance-phase lymphoma—to each hospital's infrastructure, pricing transparency, and home chemotherapy capabilities.

Key Takeaways

• Seven Hyderabad cancer centers deliver thorough blood cancer care: Yashoda Hospitals, Apollo Cancer Centre, Basavatarakam Indo American Cancer Hospital, Pace Hospital, Renova Hospitals, Dr. K K Hematology Clinic, and Pi Cancer Care

• Four tertiary hospitals—Yashoda, Apollo, Basavatarakam, and Pace—offer on-site bone marrow transplant with HLA labs, apheresis units, and 24/7 hematology emergency support for acute leukemia and complex lymphoma cases

• Home chemotherapy models reduce hospital visits and infection exposure for stable maintenance-phase patients, while subscription-based pricing provides transparent monthly costs as an alternative to fee-for-service billing

• CAR-T cell therapy for relapsed blood cancers is not yet routinely available in Hyderabad; patients requiring advanced immunotherapy are referred to specialized centers in Delhi, Mumbai, or Chennai

• Appointment pathways vary by center: tertiary hospitals typically require referrals and have 2-4 week wait times, while specialized clinics offer direct walk-in access and teleconsultation triage

What Makes a Cancer Center Thorough for Blood Cancer Care?

Thorough blood cancer care combines specialized hematology oncology for leukemia, lymphoma, and myeloma; on-site bone marrow transplant capability; outpatient chemotherapy infrastructure; and 24/7 emergency hematology support, four pillars that distinguish full-service centers from referral-only clinics in Hyderabad. No competitor page details which Hyderabad centers offer BMT on-site versus referral-only, leaving patients uncertain about treatment continuity at the point of diagnosis.

Hematology Oncology Services: Leukemia, Lymphoma, Myeloma Expertise

Specialized hematology oncologists diagnose and treat acute and chronic leukemia, Hodgkin and non-Hodgkin lymphoma, and multiple myeloma using chemotherapy, targeted therapy, and immunotherapy protocols tailored to each subtype. PACE Hospitals in Hyderabad demonstrates this approach through advanced blood tests, bone marrow examination, immunophenotyping, and molecular studies to identify disease type and stage, ensuring personalized treatment plans. NCCN Guidelines for Acute Lymphoblastic Leukemia (version 1.2026), Acute Myeloid Leukemia (version 4.2026), and B-Cell Lymphomas (version 4.2026) set the standard-of-care protocols that thorough centers must follow. Your care team should include medical oncologists trained in hematologic malignancies, pathologists with expertise in blood cancer diagnostics, and pharmacists familiar with dose adjustments for high-dose chemotherapy regimens.

Bone Marrow Transplant (BMT) Availability: On-Site Vs. Referral-Only

Bone marrow transplant is curative for many blood cancers but requires specialized infrastructure, clean rooms, HLA lab, apheresis unit, that not all oncology hospitals possess. Centers offering on-site autologous and allogeneic BMT provide treatment continuity from diagnosis through transplant, whereas referral-only clinics require patients to transfer to tertiary centers mid-treatment. The Indian Council of Medical Research's National Guidelines for Hematopoietic Cell Transplantation (January 2021) clarify that HCT has become the standard of care for numerous benign and malignant diseases and requires multidisciplinary infrastructure including infection control, dedicated blood bank support, and 24/7 hematology backup. Tata Memorial Hospital, Mumbai, performed India's first successful allogeneic BMT on March 20, 1983, establishing the template for tertiary transplant programs. When evaluating Hyderabad centers, confirm whether BMT services are delivered on-site or via referral, this distinction determines whether systemic therapy and transplant occur under a single care team or require coordination across institutions.

Outpatient Chemotherapy and 24/7 Emergency Hematology Support

Outpatient infusion centers for day chemotherapy and home chemotherapy models reduce hospital visits and infection risk while maintaining quality of life during treatment. Pi Cancer Care offers home-based chemotherapy services and 24/7 support, enabling patients to receive systemic therapy in familiar environments with continuous access to hematology expertise for febrile neutropenia and bleeding emergencies. Round-the-clock emergency hematology support is non-negotiable: neutropenic fever can progress to sepsis within hours, and thrombocytopenia-related hemorrhage requires immediate platelet transfusion. Thorough centers maintain on-call hematologists, 24/7 laboratory access for complete blood counts and coagulation panels, and protocols for urgent admission when outpatient management is insufficient. This infrastructure allows centers to deliver intensive induction chemotherapy for acute leukemia while managing complications in real time, a capability that referral-only clinics cannot provide.

Key Takeaways

• Hematology oncology expertise spans acute/chronic leukemia, Hodgkin/non-Hodgkin lymphoma, and multiple myeloma, with treatment protocols grounded in NCCN guidelines and molecular diagnostics.

• On-site BMT capability (autologous and allogeneic) distinguishes full-service centers from referral-only clinics, ensuring treatment continuity from diagnosis through transplant under a single care team.

• Outpatient chemotherapy infrastructure, including home-based delivery and day infusion centers, reduces infection risk and hospital burden while maintaining therapeutic intensity.

• 24/7 emergency hematology support is key for managing febrile neutropenia, bleeding emergencies, and acute complications of systemic therapy, requiring on-call specialists and round-the-clock laboratory access.

Understanding what thorough care requires sets the stage for evaluating which Hyderabad centers deliver it.

7 Best Cancer Centers in Hyderabad for Blood Cancer Care

Seven cancer centers in Hyderabad deliver thorough blood cancer care: (1) Yashoda Hospitals, (2) Apollo Cancer Centre, (3) Basavatarakam Indo American Cancer Hospital, (4) Pace Hospital, (5) Renova Hospitals, (6) Dr. K K Hematology Clinic, and (7) Pi Cancer Care. Each center offers distinct capabilities across hematology oncology, bone marrow transplantation (BMT), outpatient chemotherapy, 24/7 emergency support, and pricing transparency, dimensions critical for patients navigating leukemia, lymphoma, and myeloma diagnoses.

Comparison Table: Hematology Oncology, BMT, Outpatient Chemotherapy, 24/7 Support, Pricing

Yashoda Hospitals, Apollo Cancer Centre, Basavatarakam: Established Tertiary Centers With On-Site BMT

Yashoda Hospitals, Apollo Cancer Centre, and Basavatarakam Indo American Cancer Hospital anchor Hyderabad's blood cancer ecosystem as established tertiary centers with decades of multi-specialty care experience. Apollo Cancer Centre in Jubilee Hills, recognized as a leading cancer hospital in Hyderabad, provides thorough cancer care backed by a 35-year legacy and a multidisciplinary tumor board that integrates medical, surgical, and radiation oncologists for optimal treatment planning. All three institutions maintain NABH or JCI accreditation, on-site autologous and allogeneic BMT programs, and 24/7 hematology emergency support, key infrastructure for managing relapsed or refractory blood cancers that demand advanced diagnostics, targeted therapies, and stem cell transplantation.

Pace Hospital, Renova Hospitals, Dr. K K Hematology Clinic, Pi Cancer Care: Specialized Hematology Centers and Emerging Models

Pace Hospital operates a specialized hematology and BMT unit within a multi-specialty hospital, offering on-site autologous and allogeneic transplantation alongside advanced molecular diagnostics and immunotherapy. Renova Hospitals provides thorough oncology care with a hematology focus, though BMT cases are referred to partner tertiary centers when transplantation is indicated. Dr. K K Hematology Clinic functions as a dedicated outpatient hematology practice, delivering diagnostic precision and outpatient chemotherapy while referring complex BMT-eligible patients to tertiary centers for transplant evaluation.

Pi Cancer Care positions itself as one peer option among the seven, offering a differentiated model: subscription-based transparent pricing (starting at ₹3,000/month), home chemotherapy delivery for stable patients undergoing maintenance therapy, and CAR-T therapy evaluation that connects patients with India's leading CAR-T-capable centers when advanced immunotherapy is clinically indicated. This model suits patients prioritizing convenience, cost predictability, and coordinated navigation across India's blood cancer treatment ecosystem, spanning government-funded tertiary centers, charitable institutions, and specialized hematology programs. However, Pi Cancer Care does not operate on-site BMT facilities; patients requiring bone marrow transplantation are referred to tertiary partners with HEPA-filtered transplant suites, apheresis labs, and round-the-clock intensivist support.

With seven centers mapped, the decision shifts from what's available to what's right for your specific diagnosis and priorities.

How to Choose the Right Blood Cancer Center for Your Needs

Choose your blood cancer center by matching (1) your diagnosis and treatment phase to the center's capabilities, (2) your insurance coverage to accepted payment pathways, and (3) your personal priorities, proximity, appointment availability, home-based care, to the center's service model. The right fit depends on whether you need intensive inpatient care, outpatient chemotherapy, or maintenance-phase monitoring.

Matching Your Diagnosis and Treatment Phase to Center Capabilities

Acute leukemia requiring intensive induction chemotherapy and bone marrow transplant (BMT) demands a tertiary center with on-site transplant capability, 24/7 hematology backup, and a dedicated blood bank. Pace Hospital's multidisciplinary oncology team performs advanced blood tests, bone marrow examination, immunophenotyping, and molecular studies to identify disease type and stage, tailoring treatment plans for patients with leukemia, lymphoma, and multiple myeloma. Yashoda, Apollo, and Basavatarakam also maintain these capabilities.

In contrast, maintenance-phase lymphoma or myeloma patients may prioritize outpatient chemotherapy convenience over complex infrastructure. Renova and Dr. K K Hematology Clinic specialize in outpatient infusions and follow-up monitoring. Pi Cancer Care offers home chemotherapy with personalized protocols, eliminating the need for hospital visits during stable treatment phases. Match your treatment phase, induction, consolidation, or maintenance, to the center's core capability to avoid undertreatment or unnecessary facility overhead.

Insurance Coverage, Government Schemes, and Transparent Pricing Models

Payment pathways vary by center. Government schemes like Ayushman Bharat provide up to ₹5 lakh coverage, but bone marrow transplant costs in India range from ₹15 lakh for autologous BMT to ₹20-35 lakh for allogeneic BMT, requiring significant out-of-pocket top-up or NGO fundraising. Apollo, Yashoda, and Basavatarakam accept cashless private insurance and empanelment under government schemes, streamlining reimbursement for insured patients.

Patients preferring cost predictability may choose subscription-based transparent pricing. Pi Cancer Care offers subscription models starting at ₹3,000 for 3 months, locking in monthly costs upfront and eliminating claim uncertainty. This approach suits patients managing chronic conditions or maintenance therapy where treatment duration is predictable. Compare your insurance status, Ayushman Bharat, private insurance, or out-of-pocket, to each center's accepted payment pathways before committing.

Appointment Booking, Referral Pathways, and Teleconsultation Availability

Tertiary centers, Apollo, Yashoda, Basavatarakam, often have 2-4 week wait times for initial hematology consultations due to high patient volume. Referral flows typically progress from primary oncologist to hematology specialist to BMT evaluation for transplant candidates. Specialized clinics like Dr. K K Hematology Clinic and home-based models offer faster appointment slots: Pi Cancer Care provides appointment booking and teleconsultation for follow-up visits, a practical consideration for patients requiring urgent second opinions or treatment adjustments.

If proximity matters, living far from Hyderabad's tertiary hubs, teleconsultation availability becomes critical. Your care team can coordinate remote follow-up monitoring, reducing travel burden during maintenance-phase systemic therapy. Evaluate each center's appointment booking process, referral requirements, and teleconsultation options to ensure timely access when treatment urgency demands it.

Choose Your Hyderabad Blood Cancer Center

Tertiary cancer hospitals, Apollo, Yashoda, Basavatarakam, offer thorough multi-specialty backup and on-site BMT but may have longer appointment wait times and higher out-of-pocket costs. Specialized hematology centers like Pace and Dr. K K Hematology Clinic provide faster access and focused blood cancer expertise but refer complex BMT cases to partner institutions. Home chemotherapy models like Pi Cancer Care's reduce hospital visits and infection exposure for stable maintenance-phase patients, though intensive induction chemotherapy for acute leukemia still requires in-hospital administration at a tertiary center with 24/7 hematology support.

As CAR-T cell therapy and targeted therapies for blood cancers become more widely available in India, Hyderabad's cancer centers are expanding their hematology infrastructure. Expect more centers to offer on-site BMT, clinical trial access, and advanced immunotherapies in the next 2-3 years, making thorough blood cancer care increasingly accessible within the city rather than requiring referrals to Mumbai or Delhi.

Compare the seven centers' hematology services, BMT availability, and pricing models using the table above, then book a consultation at the center that matches your diagnosis and insurance coverage. Or schedule a free teleconsultation with Pi Cancer Care to discuss your case and receive a personalized referral pathway if a tertiary center is more appropriate for your treatment phase.

Frequently Asked Questions

Which Hyderabad hospitals offer on-site bone marrow transplant for blood cancer?

Four Hyderabad centers provide on-site autologous and allogeneic BMT programs: Yashoda Hospitals, Apollo Cancer Centre (Jubilee Hills), Basavatarakam Indo American Cancer Hospital, and Pace Hospital. These facilities maintain specialized infrastructure, HLA labs, apheresis units, clean rooms, required for transplant. Other centers refer complex BMT candidates to these four or to Tata Memorial and RGCIRC for specialized cases.

Does any Hyderabad cancer center offer home chemotherapy for blood cancer patients?

Pi Cancer Care offers home chemotherapy delivery for stable blood cancer patients in maintenance phase, with trained nurses administering oral and select IV regimens at home. This model reduces hospital visits and infection exposure while maintaining quality of life. Intensive induction chemotherapy for acute leukemia still requires in-hospital administration at any tertiary center with 24/7 hematology backup.

How much does blood cancer treatment cost in Hyderabad, and does Ayushman Bharat cover it?

Chemotherapy for leukemia or lymphoma costs ₹2-8 lakh per cycle; autologous BMT ₹15-25 lakh; allogeneic BMT ₹20-35 lakh. Ayushman Bharat provides up to ₹5 lakh coverage, partially subsidizing treatment but requiring out-of-pocket top-up for BMT. Pi Cancer Care's subscription model offers transparent monthly pricing starting at ₹3,000, covering consultations, chemotherapy, and home care as an alternative to fee-for-service uncertainty.

What is CAR-T cell therapy, and is it available for blood cancer in Hyderabad?

CAR-T (chimeric antigen receptor T-cell therapy) is an advanced immunotherapy for relapsed/refractory B-cell lymphomas and acute lymphoblastic leukemia, approved in India since 2021. It's available at select centers, RGCIRC Delhi, Tata Memorial Mumbai, Apollo Chennai, but not yet routinely in Hyderabad. Patients requiring CAR-T are referred to these specialized facilities for treatment.

How do I book an appointment at a blood cancer center in Hyderabad?

Three pathways exist: (1) Direct walk-in or phone booking at specialized hematology clinics like Dr. K K Hematology Clinic and Renova; (2) Referral from a general oncologist to hematology departments at tertiary hospitals, Apollo, Yashoda, Basavatarakam, Pace, often requiring prior medical records ; (3) Online scheduling via hospital websites or aggregators like Practo. Pi Cancer Care offers teleconsultation for initial triage, expediting access for urgent cases.

What blood cancer conditions are treated at Hyderabad cancer centers?

Thorough centers treat acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, non-Hodgkin lymphoma (diffuse large B-cell, follicular, mantle cell), multiple myeloma, and myelodysplastic syndromes (MDS). Specialized hematology oncologists use chemotherapy, targeted therapy, and immunotherapy protocols tailored to each subtype. Some clinics focus on specific conditions like CML-only practices.

Do Hyderabad blood cancer centers offer 24/7 emergency hematology support?

Tertiary cancer hospitals, Yashoda, Apollo, Basavatarakam, Pace, provide 24/7 emergency hematology support for complications like febrile neutropenia, tumor lysis syndrome, and bleeding episodes. Smaller specialized clinics have on-call hematologists but may refer emergency cases to tertiary centers after-hours. Pi Cancer Care offers 24/7 teleconsultation triage with home-visit capability for stable emergencies but refers unstable patients to partner hospitals.

Sources

1. Best Hospital for Blood Cancer Treatment in Hyderabad, India — Pace Hospital - pacehospital.com

2. National Guidelines for Hematopoietic Cell Transplantation — ICMR - icmr.gov.in (2021)

3. Treatment by Cancer Type — NCCN Guidelines - nccn.org

4. Best Blood Cancer Hospital in Delhi, India — RGCIRC - www.rgcirc.org

5. CAR-T Cell Therapy for Blood Cancers in India (2025) — CAR-T Israel - car-t-access.org (2025)

6. Bone Marrow Transplant Cost and Factors Affecting the Price — Medicover Hospitals - www.medicoverhospitals.in